Reuters: Avastin slows progress of breast cancer in trial

[NaDiNe]

Avastin slows progress of breast cancer in trial
      

CHICAGO (Reuters) - The addition of Genentech Inc's cancer drug Avastin to chemotherapy slows the progress of breast cancer at two different doses, according to results of a large international trial released on Saturday.
<p>You are not allowed to view links. Register or Login</p><div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login